Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 6/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29356117 | 0.91 | ERN1 (0.60) | ERN1POLBGAARAB9AALDH1A1 | |
| SCHEMBL131222 | 0.91 | ERN1 (0.60) | ERN1POLBGAARAB9AALDH1A1 | |
| Acetone SCHEMBL22719929 | 0.82 | ERN1 (0.61) | ERN1POLBGAARAB9AALDH1A1 | |
| Sulfuric Acid SCHEMBL9048559 | 0.82 | ERN1 (0.55) | ERN1POLBGAARAB9AALDH1A1 | |
| SCHEMBL4962062 | 0.79 | ALDH1A1 (0.46) | ERN1POLBGAARAB9AALDH1A1 | |
| Acetic Acid SCHEMBL724536 | 0.79 | ERN1 (0.57) | ERN1POLBGAARAB9AALDH1A1 | |
| Ethylene Glycol SCHEMBL640721 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10TDP1RECQL | |
| Pyrogallol SCHEMBL28732500 | 0.77 | ALDH1A1 (0.75) | ERN1POLBGAARAB9AALDH1A1 | |
| Ethylene Glycol SCHEMBL4453630 | 0.76 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10 | |
| SCHEMBL4850054 | 0.74 | ERN1 (0.56) | ERN1POLBGAARAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3270949-A2 | INSULIN ANALOGUES CONTAINING A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | Case Western Reserve University (US) | 2018-01-24 | — | — | EP | claimed |
| WO-2016149222-A2 | INSULIN ANALOGUES CONTAINING A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | CASE WESTERN RESERVE UNIVERSITY (US) | 2016-09-22 | — | — | WO | claimed |
| EP-3148662-B1 | EXTRACTION, DERIVATIZATION, AND QUANTIFICATION OF ANALYTES | TECAN SP INC (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-3270949-B1 | INSULIN ANALOGUES CONTAINING A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | UNIV CASE WESTERN RESERVE (US) | 2025-01-29 | — | — | EP | disclosed |
| US-20240218041-A1 | MOLECULAR DESIGN OF GLUCOSE SENSORS IN GLUCOSE-RESPONSIVE INSULIN ANALOGUES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-07-04 | — | — | US | disclosed |
| EP-4334338-A1 | MOLECULAR DESIGN OF GLUCOSE SENSORS IN GLUCOSE-RESPONSIVE INSULIN ANALOGUES | The Trustees of Indiana University (US) | 2024-03-13 | — | — | EP | disclosed |
| US-20230399373-A1 | MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES | THE TRUSTEES OF INDIANA UNIVERSITY | 2023-12-14 | — | — | US | disclosed |
| EP-4232464-A1 | MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES | The Trustees of Indiana University (US) | 2023-08-30 | — | — | EP | disclosed |
| US-11739345-B2 | Methods of treating phenylketonuria | BIOMARIN PHARMACEUTICAL INC. (US) | 2023-08-29 | — | — | US | disclosed |
| WO-2022235691-A1 | MOLECULAR DESIGN OF GLUCOSE SENSORS IN GLUCOSE-RESPONSIVE INSULIN ANALOGUES | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2022-11-10 | — | — | WO | disclosed |
| US-20220288213-A1 | INSULIN ANALOGUES WITH GLUCOSE REGULATED CONFORMATIONAL SWITCH | THERMALIN INC (US) | 2022-09-15 | — | — | US | disclosed |
| EP-3790627-A2 | METHODS OF TREATING PHENYLKETONURIA | BioMarin Pharmaceutical Inc. (US) | 2021-03-17 | — | — | EP | disclosed |
| US-10584156-B2 | Insulin analogues with a glucose-regulated conformational switch | CASE WESTERN RESERVE UNIVERSITY (US) | 2020-03-10 | — | — | US | disclosed |
| WO-2019217513-A2 | METHODS OF TREATING PHENYLKETONURIA | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-11-14 | — | — | WO | disclosed |
| US-10267775-B2 | Extraction, derivatization, and quantification of analytes | TECAN SP, INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-20180057559-A1 | INSULIN ANALOGUES WITH A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | CASE WESTERN RESERVE UNIVERSITY | 2018-03-01 | — | — | US | disclosed |
| EP-3270949-A2 | INSULIN ANALOGUES CONTAINING A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | Case Western Reserve University (US) | 2018-01-24 | — | — | EP | disclosed |
| EP-3148662-A1 | EXTRACTION, DERIVATIZATION, AND QUANTIFICATION OF ANALYTES | SPEware Corporation (US) | 2017-04-05 | — | — | EP | disclosed |
| WO-2016149222-A2 | INSULIN ANALOGUES CONTAINING A GLUCOSE-REGULATED CONFORMATIONAL SWITCH | CASE WESTERN RESERVE UNIVERSITY (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20150346170-A1 | Extraction, Derivatization, and Quantification of Analytes | QUANTALYTICAL LABS INC. (US) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220288213-A1 | INSULIN ANALOGUES WITH GLUCOSE REGULATED CONFORMATIONAL SWITCH | IAPP, GPR119, INSR | ERN1 247/4885POLB 3425/4885GAA 242/4885 |
| US-20240218041-A1 | MOLECULAR DESIGN OF GLUCOSE SENSORS IN GLUCOSE-RESPONSIVE INSULIN ANALOGUES | IAPP, GPR119, INSR | ERN1 1160/4885POLB 3122/4885GAA 2154/4885 |
| US-11739345-B2 | Methods of treating phenylketonuria | PAH, PNMT, AADAT | ERN1 2956/4885POLB 1744/4885GAA 36/4885 |
| US-20230399373-A1 | MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES | IAPP, GPR119, INSR | ERN1 589/4885POLB 1797/4885GAA 203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.